- The Fund’s longstanding overweight in the Industrials sector weighed on returns amid tariff-related uncertainty, but we still favour these stocks for their strong IP, global distribution reach and robust – if cyclical – cash flows.
- Despite ongoing style and size headwinds, we remain committed to high-quality compounders; with valuations at extreme lows, we believe this presents a rare and compelling entry point.
- We believe several factors are aligning to create a more supportive environment for UK equities, particularly quality growth names in the mid and small-cap space.
The Liontrust GF UK Growth Fund returned -2.7%* in April. The Fund’s comparator benchmark, the FTSE All-Share, returned -0.3%.
UK equity markets initially endured a sharp sell-off after sweeping tariffs announced by US President Donald Trump – dubbed "Liberation Day" – sent shockwaves through global markets. However, sentiment improved later in the month following a shift in the US administration's approach, including a 90-day delay on tariffs for non-retaliatory countries and the removal of duties on a range of electronic goods. This softening in tone provided reassurance to investors and supported a partial recovery in stock prices.
A significant driver of the Fund’s underperformance was its longstanding overweight in the Industrials sector, favoured for its companies’ strong intellectual property, global distribution reach, and robust, though somewhat cyclical, cash flow returns on invested capital.
The sector, however, bore the brunt of the tariff uncertainty, with constituent names exposed to a broad-based sell-off as investors digested the implications of both direct tariff exposure and potential second-order effects on global economic growth. As the Fund’s holdings in the sector are generally comprised of businesses with broad global footprints (lending a degree of flexibility in terms of optimising manufacturing and distribution) and strong pricing power, we feel that the first-order effects of tariffs on our companies’ trading are well-contained. However, it is impossible to predict any secondary effects stemming from weaker global growth and this wider uncertainty weighed heavily on sentiment, as it also did for the Fund’s holdings in BP (-20%) and Shell (-14%).
A number of the Fund’s Industrials holdings updated on trading during the month, with positive announcements coming from Coats (-8.4%, which disposed of its US Yarns business, a move which should be accretive to margin) and Weir Group (-2.0%, which reported on positive order book trends for Q1 and held its outlook steady for the year).
Recruiter PageGroup (-11%) reported on ongoing difficult trading, with the uncertain backdrop understandably weighing on client and candidate confidence. However, we retain our confidence in the strength of the underlying business, which boasts a strong net-cash balance sheet and an experienced management team who are well versed in managing through past economic cycles.
Unexpected negative updates came, however, from both RWS Holdings and Bunzl. RWS Holdings (-44%) released a deeply frustrating trading update in which it alerted the market that despite returning to organic growth, mix issues and pricing pressure were impacting margin, resulting in a ~30% downgrade to consensus earnings. A new CEO has recently taken the helm and purchased a significant amount of stock following the warning.
Bunzl’s (-21%) profit warning caught the market, and the team, completely off guard, coming from a company with a long-standing track record of forecasting reliability. The warning stemmed from operational issues within its large US foodservice subsidiary, compounded by slight softness in the backdrop thanks to the macroeconomic uncertainty, prompting a ~10% downgrade. The share price fall brought the stock’s valuation to a level not seen since the global financial crisis, and after a reassuring meeting with management, we remain confident in the position and have topped up our holding.
Turning to the positives, Indivior (+17%) reported Q1 net revenue of $266 million, exceeding the consensus estimate of $243 million. Alongside the strong top-line performance, the company reaffirmed its full-year 2025 financial guidance, reinforcing confidence in the outlook and the turnaround strategy catalysed by the arrival of the activist investor Oaktree Capital on the shareholder register late last year.
Once again, BAE Systems (+13%) was among the top performers, as defence stocks continue to benefit from a sustained re-rating. This has been driven by escalating geopolitical tensions and enduring commitments to higher defence spending across Europe.
Shares in Moonpig (+9.5%) strengthened after the group released a solid trading update outlining in-line revenue and adjusted EBITDA margin at the top end of its guidance range, alongside strong cash generation, which prompted it to announce a £60 million extension to its inaugural £25 million share buyback programme.
Gamma Communications (+10%) saw a partial recovery after the majority of the temporary stock overhang was cleared ahead of its early May move from the AIM to the Main Market, easing selling pressure and improving market sentiment.
While the persistence of style and size headwinds over recent years has been frustrating, our investment philosophy remains rooted in owning high-quality businesses with strong competitive advantage and the ability to compound returns over time. With valuations for such companies now at almost unprecedented lows, we see this as a rare and compelling entry point.
We believe several factors are aligning to create a more supportive environment for UK equities, particularly quality growth names in the mid and small cap space. US President Donald Trump’s recent actions have triggered a reassessment of the relative appeal of US versus international markets, including the UK, while also raising the likelihood of faster interest rate cuts, which would benefit the asset class.
There is also growing momentum around potential government policy support. We have engaged extensively with both government and regulators on issues including AIM, pension reform, and the regulatory burden on listed companies, and have been encouraged by their willingness to strengthen the UK’s capital markets.
This combination of improving relative asset allocation dynamics and potential policy action underpins our increasing confidence that capital will begin to flow back into the market.
Positive contributors included:
BAE Systems (+13%), Moonpig (+9.5%), RELX (5.0%), Unilever (+3.2%), Gamma Communications (+10%)
Negative contributors included:
Shell (-14%), BP (-20%), Bunzl (-21%), AstraZeneca (-4.7%) and RWS Holdings (-43%)
Discrete years' performance** (%) to previous quarter-end:
Past performance does not predict future returns
|
Mar-25 |
Mar-24 |
Mar-23 |
Mar-22 |
Mar-21 |
Liontrust GF UK Growth C3 Inst Acc GBP |
0.3% |
7.2% |
3.3% |
13.1% |
23.5% |
FTSE All Share |
10.5% |
8.4% |
2.9% |
13.0% |
26.7% |
|
Mar-20 |
Mar-19 |
Mar-18 |
Mar-17 |
Mar-16 |
Liontrust GF UK Growth C3 Inst Acc GBP |
-18.5% |
6.4% |
1.3% |
22.0% |
1.9% |
FTSE All Share |
-13.5% |
6.4% |
2.0% |
21.9% |
-3.9% |
*Source: Financial Express, as at 30.04.25, total return (net of fees and income reinvested), sterling terms, C3 institutional class. Non fund-related return data sourced from Bloomberg. **Source: Financial Express, as at 31.03.25, total return (net of fees and income reinvested), primary class. Investment decisions should not be based on short-term performance.
Key Features of the Liontrust GF UK Growth Fund
KEY RISKS
Past performance is not a guide to future performance. The value of an investment and the income generated from it can fall as well as rise and is not guaranteed. You may get back less than you originally invested.
The issue of units/shares in Liontrust Funds may be subject to an initial charge, which will have an impact on the realisable value of the investment, particularly in the short term. Investments should always be considered as long term.
Past performance does not predict future returns. You may get back less than you originally invested.
We recommend this fund is held long term (minimum period of 5 years). We recommend that you hold this fund as part of a diversified portfolio of investments.
- The Fund may encounter liquidity constraints from time to time. The spread between the price you buy and sell shares will reflect the less liquid nature of the underlying holdings.
- The Fund may invest in companies listed on the Alternative Investment Market (AIM) which is primarily for emerging or smaller companies. The rules are less demanding than those of the official List of the London Stock Exchange and therefore companies listed on AIM may carry a greater risk than a company with a full listing.
- Outside of normal conditions, the Fund may hold higher levels of cash which may be deposited with several credit counterparties (e.g. international banks). A credit risk arises should one or more of these counterparties be unable to return the deposited cash.
- Counterparty Risk: any derivative contract, including FX hedging, may be at risk if the counterparty fails.
DISCLAIMER
This material is issued by Liontrust Investment Partners LLP (2 Savoy Court, London WC2R 0EZ), authorised and regulated in the UK by the Financial Conduct Authority (FRN 518552) to undertake regulated investment business.
It should not be construed as advice for investment in any product or security mentioned, an offer to buy or sell units/shares of Funds mentioned, or a solicitation to purchase securities in any company or investment product. Examples of stocks are provided for general information only to demonstrate our investment philosophy. The investment being promoted is for units in a fund, not directly in the underlying assets.
This information and analysis is believed to be accurate at the time of publication, but is subject to change without notice. Whilst care has been taken in compiling the content, no representation or warranty is given, whether express or implied, by Liontrust as to its accuracy or completeness, including for external sources (which may have been used) which have not been verified.
This is a marketing communication. Before making an investment, you should read the relevant Prospectus and the Key Investor Information Document (KIID) and/or PRIIP/KID, which provide full product details including investment charges and risks. These documents can be obtained, free of charge, from www.liontrust.co.uk or direct from Liontrust. If you are not a professional investor please consult a regulated financial adviser regarding the suitability of such an investment for you and your personal circumstances.